Labshake search

1 - 6 of 6 citations for CCL24 Eotaxin 2 Human since 2019

• Muscle group specific transcriptomic and DNA methylation differences related to developmental patterning in FSHD

  Katherine Williams, et al., bioRxiv - Genomics 2021

  Quote: ... and 2% Ultrasor G (Crescent Chemical Co.). Day 0 cells were kept at low confluency to prevent spontaneous differentiation ...
• Single-nucleus RNA-seq identifies divergent populations of FSHD2 myotube nuclei

  Shan Jiang, et al., bioRxiv - Genomics 2019

  Quote: ... and 2% Ultrasor G (Crescent Chemical Co.) [21] ...
• Deubiquitinase UCHL1 Maintains Protein Homeostasis through PSMA7-APEH-Proteasome Axis in High-Grade Serous Ovarian Carcinoma

  Apoorva Tangri, et al., bioRxiv - Cancer Biology 2020

  Quote: ... supplemented with 2% UltroserG (Crescent Chemical Company). Non-ciliated FT epithelial (FNE ...
• Relationship of DUX4 and target gene expression in FSHD myocytes

  Jonathan Chau, et al., bioRxiv - Genetics 2020

  Quote: ... and 2% Ultrasor G (Crescent Chemical Co.). Primary control and FSHD2 myoblasts (24 ...
• Engineered SMCHD1 and D4Z4 mutations reveal roles of D4Z4 heterochromatin disruption and feedforward DUX4 network activation in FSHD

  Xiangduo Kong, et al., bioRxiv - Genetics 2022

  Quote: ... and 2% Ultrasor G (Crescent Chemical Co.). Immortalization and single cell clone isolation of primary FSHD1 myoblasts were performed as previously described for Control and FSHD2 myoblasts (60) ...
• Durable Changes to Airway Mucus and Fluid Secretion Following Cholinergic Challenge

  Yan Shin J. Liao, et al., bioRxiv - Physiology 2020

  Quote: ... Medium consisted of DMEM/F12 supplemented with 2% Ultroser G (USG, Crescent Chemical) and antibiotics as previously described [26] ...